Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Bedrosian

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Virology|February 1, 1990
The DNA-binding domain of HPV-16 E2 protein interaction with the viral enhancer: protein-induced DNA bending and role of the nonconserved core sequence in binding site affinityC L Bedrosian, D Bastia
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Escherichia coli replication terminator protein impedes simian virus 40 (SV40) DNA replication fork movement and SV40 large tumor antigen helicase activity in vitro at a prokaryotic terminus sequenceC L Bedrosian, D Bastia
Seminars in Hematology|July 13, 2001
Clinical evaluation of B-domain deleted recombinant factor VIII in previously treated patientsS G Courter, C L Bedrosian
Southern Medical Journal|April 1, 1987
Cold hemagglutinin disease in the operating roomC L Bedrosian, D L Simel
Seminars in Hematology|July 13, 2001
Clinical evaluation of B-domain deleted recombinant factor VIII in previously untreated patientsS G Courter, C L Bedrosian
American Journal of Hematology|September 1, 1988
Antifibrinolytic therapy in the management of the Kasabach Merritt syndromeT L Ortel, J J Onorato, C L Bedrosian, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 1, 2003
The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia AJ M Lusher, C A Lee, C M Kessler, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1994
A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neckD M Brizel, K A Leopold, S R Fisher, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Virology|February 1, 1990
The DNA-binding domain of HPV-16 E2 protein interaction with the viral enhancer: protein-induced DNA bending and role of the nonconserved core sequence in binding site affinityC L Bedrosian, D Bastia
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Escherichia coli replication terminator protein impedes simian virus 40 (SV40) DNA replication fork movement and SV40 large tumor antigen helicase activity in vitro at a prokaryotic terminus sequenceC L Bedrosian, D Bastia
Seminars in Hematology|July 13, 2001
Clinical evaluation of B-domain deleted recombinant factor VIII in previously treated patientsS G Courter, C L Bedrosian
Southern Medical Journal|April 1, 1987
Cold hemagglutinin disease in the operating roomC L Bedrosian, D L Simel
Seminars in Hematology|July 13, 2001
Clinical evaluation of B-domain deleted recombinant factor VIII in previously untreated patientsS G Courter, C L Bedrosian
American Journal of Hematology|September 1, 1988
Antifibrinolytic therapy in the management of the Kasabach Merritt syndromeT L Ortel, J J Onorato, C L Bedrosian, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 1, 2003
The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia AJ M Lusher, C A Lee, C M Kessler, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1994
A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neckD M Brizel, K A Leopold, S R Fisher, et al.
Pageof 1